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The biological events that occur in cells after contact with tolerogen are still largely 
unknown,  and  Burnet's  thesis  (1)  that  the  deletion of  such  specific cells may be a 
prerequisite for a  state of immunological unresponsiveness remains without substan- 
tial experimental evidence. Binding of highly radioactive labeled antigen  to specific 
]ymphocytes as visualized by means of autoradiography has provided a  method  of 
searching for specific antigen-binding cells (ABC) 1 in  immunologically unresponsive 
animals. On the one hand, Ada et al. (2)  and Cooper et al.  (3) found a  normal com- 
plement of ABC to flagellin and hemocyanin in animals unresponsive to these antigens; 
and  Humphrey  and  Keller  (4),  using  hemocyanin  and  the  synthetic  polypeptide 
TIGAL as antigens, also concluded that unresponsive animals possessed a  number of 
ABC similar to  that seen in normal mice. On the other hand,  Naor and  Sulitzeanu 
(5)  and  Katz  etal.  (6)  found  a  decrease in  specific ABC  in  animals unresponsive, 
respectively, to bovine serum albumin (BSA) and the dinitrophenol (DNP) hapten. 
In the present report, the fate of ABC was investigated kinetically in a system 
of immunologic unresponsiveness in which a complete, long-lasting, and specific 
tolerant state can be induced, namely, unresponsiveness in adult mice to mono- 
meric  gamma  globulin.  Since  the  cellular events  functional  in  the  induction 
process of this unresponsive state have been described (7), they provide a  basis 
on  which  to  evaluate  the  morphological  data  obtained  by  the  technique  of 
antigen binding. 
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Materials  and Methods 
Animals.-  A/J  male  mice  were  obtained  from  the  Jackson  Laboratory,  Bar  Harbor, 
Maine. They were 8 -10 wk of age at the time of use. 
Antigen:  Tolerogen and [mmunogen.  -Human gamma globulin (HGG,  Cohn fraction If) 
was obtained through the courtesy of the American Red Cross. In a  manner previously de- 
scribed  (8),  DEAE-purified HGG was employed for the preparation of either deaggregated 
HGG  (DHGG)  for use as the toIerogenic material or aggregated HGG  (AHGG) for use as 
the immunogenic material. 
Labeling of Antigen.. IIGG  was iodinated using the chloramine-T method  (9)  in micro- 
volumes (10).  2-4 mCi of 12~I (carrier-free [125I]Na,  Cambridge Nuclear Corp.,  Cambridge, 
Mass.) in 50 #1 was neutralized to pH  7.0 by 25 #l of 0.1  M  NaH2PO4.40/~1 of a  solution 
of HGG (250 jzg/ml) and 5 #1 of chloramine-T (5 mg/ml) were added to the l~-r'I  solution, and 
the mixture was allowed to react for 5 rain. After this, 5/zl of sodium metabisulfite (.5 mg/ml), 
1 drop of 1% potassium iodide, and 0.5 ml of fetal calf serum (Grand Island Biological Co., 
Grand Island, N. Y.) were added to the mixture. In order to remove free iodine, the solution 
was passed through a Sephadex G-25 column  (Pharmacia Fine Chemicals, Inc.,  Piscataway, 
N. J.). 
Preparation oj Cells.--Spleen,  bone marrow, and thymus were collected in minimal essential 
medium (MEM) containing 10% fetal calf serum and prepared as single-cell suspensions as 
described elsewhere (8). 
Autoradiography. -The technique of Davie and Paul (11) was used, with minor modifica- 
tions. Lymphoid cells (20 X  106) were suspended in MEM  (200/zl) containing 10% fetal calf 
serum and sodium azide  (15  raM).  /12511HGG (100  ng in 10 /xl, with a  specific  activity of 
50-70 #Ci//zg) was added to the cell suspension for 30 rain. The cells were then layered over 
5 ml of fetal calf serum and harvested by centrifugation at 180 g for 10 rain. This last step 
was repeated three times. All the preceding operations were performed at 4°C. 
The cells were smeared on methanol-cleaned microscopic slides, fixed in 1% glutaraidehyde, 
washed in water, and air dried. The smears were dipped in a solution of NTB2 nuclear track 
emulsion  (Eastman Kodak Co.,  Rochester, N. Y.)  and exposed for 1 mo before developing. 
Before examination, the cells were stained with Giemsa. Only morphologically intact lymphoid 
cells with 15 silver grains were considered to he ABC. 
inhibition of [  1  ~  5[][tGG Binding by Unlabeled Antigen.--'['he  lymphoid cells were incubated 
with unlabeled proteins at 4°C  for 30 min, harvested by centrifugation through 3 ml of fetal 
calf serum, suspended in 200 gl of medium, and then incubated with [12alIHGG and processed 
as described above. 
RESULTS 
Binding  of  [~2~I]HGG to  Lymphoid  Cells;  Speclificity.--The  number  of  ABC 
to HGG  found in the spleen of normal A/J  mice varied from 9 to 14 in 5,000 cells 
counted. In the bone marrow this number varied from I0 to 14. The thymus was 
found to contain a  very low number  of ABC  to HGG.  In some experiments no 
positive cells were found, whereas in others one positive cell was found in 10,000 
cells counted. 
In  order  to  demonstrate  that  this binding was  specific for HGG,  unlabeled 
HGG  or unlabeled non-cross-reacting antigens, such as turkey gamma  globulin 
(TGG)  or keyhole limpet hemocyanin  (KLH),  were incubated with the lymph- 
old cells before the reaction with [~2'~I]HGG was undertaken. The results of one 
such inhibition experiment performed with spleen cells are given in Table I. It 
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was able to inhibit the [t2~I]HGG binding and that no inhibition was observed 
with imnmnologically unrelated and unlabeled proteins. 
Table II shows the results of such an inhibition experiment performed with 
bone  marrow  (BM)  cells.  Unlabeled  HGG  was  also  found  to  decrease  the 
[~2~I]HGG binding by BM  cells,  but the dose required  to inhibit these ABC  (2.4 
rag) was 6 times greater than that needed to inhibit ABC obtained from spleens. 
Furthermore,  the same amount of TGG, i.e.  2.4 mg, was able to decrease par- 
tially  the  [~%I]HGG binding  in  bone marrow.  The paucity  of ABC  to HGG 
TABLE  I 
Inhibition  of [1%I]IIGG Binding  by Lymphocyles from  Normal  Spleens  by Preincubation  of 
the Cells with  Unlabeled I[GG,  TGG, or KLH 
Inhibitor  Amount  Inhibition  of [125I]IIGG  binding 
mg  ~ 
HGG  0.3  22 
HGG  0.6  67 
HGG  1.2  89 
TGG  I. 2  0 
KLH  1.2  1l 
TABLE  II 
Inhibition of [I~[]HGG Binding by Lymphocytes from Normal Bone Marrow by Preincubation 
of the Cells with Unlabeled HGG, TGG, or KLtI 
Inhibitor  Amount  Inhibition  of [125I]HGG  binding 
mg  % 
HGG  0.6  18 
HGG  1.2  36 
HGG  2.4  76 
TGG  2.4  38 
KLH  1.2  18 
observed in the thynms made such inhibition experiments  with  cells from this 
tissue  impossible. 
Effect of Tolerogen and Immunogen on the Number of A BC in Lymphoid Tissues 
oJ Mice.--To  study  the  kinetics  of  ABC  to  HGG  in  lymphoid  tissues  after 
various antigenic treatments, mice were injected on day 0 either with a tolero- 
genic dose of 2.5 mg of DHGG intraperitoneally or with an immunogenic dose 
of 0.4 mg of AHGG.  A  group of saline-injected  mice  served as a  control.  At 
various  times after  injection,  the animals  were killed by cervical  dislocation: 
and their spleens, bone marrow, and thymuses were assayed for ABC to HGG. 
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pool comiag from two mice; and a minimum of 5 X  103 cells were counted unless 
otherwise specified. 
The  results  obtained  with  spleen  cells  from these  experimental  groups are 
presented in Fig. 1. In the spleens of saline-injected mice, the number of ABC in 
5,(]00 cells  counted varied from 9 to  14.  In contrast,  the spleen  of tolerogen- 
injected animals displayed a lower number of ABC. As early as 12 h after the 
injection of 2.5 mg of DHGG, the number of ABC decreased to approximately 
half the  amount seen  in normal animals.  5 days after tolerogen injection,  the 
decrease ic~ ABC was essentially' maximal. At day 20 the spleens  of unresponsive 
animals  contained  10  times  less  ABC  than  that  found in  the  spleens  of  the 
control mice. 
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FIG. 1.  Kinetics of ABC to HGG in the spleen of mice after injection of either tolerogen 
(deaggregated HGG), immunogen (aggregated HGG), or saline, Each point represents an 
average of four counts of ABC, each done a with different cell pool  of two spleens. A minimum 
of 5 X 103 spleen cells were counted. 
The number of ABC to HGG in the spleens of immunogen-treated mice began 
to increase as soon as 24 h  after the injection of 0.4 mg of AHGG, reaching a 
peak on day 3 of three times that number found in normal animals. After this 
day, the number of ABC in the immunogen-injected group began to decrease; 
and on the last experimental day, day 20, the number of ABC was only slightly 
higher than that seen in the spleens  of normal mice.  However, when 20 X  106 
spleen  cells  obtained from animals primed  with  AHGG 20 days earlier  were 
incubated with unlabeled HGG before reaction with  [125I]HGG, it was found 
that as little  as 0.3  mg of unlabeled HGG was able to abolish completely the 
binding of [I=aI]HGG  by these cells, whereas the same amount of unlabeled HGG 
incubated with normal spleen  cells did not diminish the number of ABC found 
in this population. 
The kinetic pattern of ABC to HGG in bone marrow cells in the three experi- 
mental  situations is seen  in Fig. 2. In the saline-injected mice,  the number of 
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the number of ABC seen in the bone marrow was similar to that seen in normal 
mice until day 20, when there was a decrease of ABC in tolerogen-treated  BM 
cells to two-thirds of the number seen in the bone marrow of normal animals. In 
contrast to that observed in the spleen,  the number of ABC in the bone marrow 
of immunogen-injected mice was the same as that found in normal bone marrow. 
The paucity of ABC to HGG displayed by the thymus (T) cells did not allow  a 
difference between the three experimental conditions (Table III). 
DISCUSSION 
The present data demonstrate that the induction of an unresponsive state to 
HGG in mice is concomitant with the disappearance of specific HGG-binding 
cells normally located in the spleen  and in the bone marrow. In the spleen,  the 
diminution of these ABC begins as soon as 12 h after the injection of tolerogen, 
reaching an optimal reduction by the 5th day. In the bone marrow, there is a lag 
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FIG.  2.  Kinetics  of ABC  to  HGG in  the  bone marrow of mice  after  injection  of  either 
tolerogen  (deaggregated HGG), immunogen (aggregated HGG), or saline. Each point repre- 
sents an average of four counts of ABC, each done with a  different ceil pool coming from the 
bone marrow of two mice. A minimum of 5  >(  10 3 BM cells were counted. 
TABLE  III 
Quantitation  of A BC to IIGG in T Cells Obtained from Mice after the Injection of Either  Tolerogen 
(Deaggregated  HGG),  Immunogen  (Aggregated  HGG),  or  Saline 
Injection at day 0 
No. of ABC/10  4 thymus cells 
Day after injection 
0.5  1  3  5  10  20 
0.4 mg aggregated HGG  1"  1  <1  <1  1  0 
Saline  <  1"  0  1  1  1  < 1 
2.5  mg deaggregated HGG  <1:~  0  <1  <1  1  <1 
* Each number in the series is an average of three counts of ABC, each one done with a 
different cell  pool of two thymuses. A minimum of 10  4 thymus cells were counted. 
:~ Each number in the series is an average of four counts of ABC, each one done with a 
different  cell  pool  of  two thymuses. A  minimum of  10  4 thymus cells were counted. 466  FATE  OF  ANTIGEN-BINDING  CELLS 
period before a diminution of ABC  is observed in that  a  significant reduction 
does not occur until between days 10 and 20 after tolerogen injection. Although 
an attempt was made to quantitate differences of ABC in the thymus, signifi- 
cant  data were not  obtained because of the paucity of ABC  to  HGG in  the 
thymuses of normal A/J mice. 
The kinetic pattern in the reduction of ABC during induction  of unrespon- 
siveness demonstrates a  remarkable parallelism with previous observations in 
which  the response capacity of various cell  populations  after the injection  of 
tolerogen  (7)  was  monitored;  that  is,  the  reduction  in  functional  immuno- 
competence of the B cells of the spleen  2 corresponds to the maximal reduction of 
ABC  observed  in  the  spleen,  and  the  15  21-day  latent  period  required  for 
specific BM cells to become tolerant (7) is the same as that required for specific 
BM cells to lose their capacity as ABC. 
The observed disappearance of specific lymphocytes in animals rendered un- 
responsive is a phenomenon that may be explained bv at least four alternative 
mechanisms.  First,  specific cells may have been  eliminated  after contact with 
tolerogen;  second,  the  cells may have left the  tissues  scanned  in  the  present 
study;  third,  receptors of specific antigen-sensitive cells may have been satu- 
rated with the tolerogen; and fourth, receptors may have been stripped off the 
specific cells as a result of contact with tolerogen. 
The first mechanism, i.e. clonal elimination of specific cells after contact with 
tolerogen, is a concept that gains support from the data obtained by Azar and 
Good (12).  They reported that the development of tolerance to deaggregated 
bovine gamma globulin is inhibited in mice depleted of complement and  sug- 
gested that complement-mediated cytolysis eliminated specific cells. In addition, 
the  fact  that  thymectomy (13)  and bursectomy  (14)  prolong  and  sometimes 
abrogate the termination of tolerance supports the conclusion that termination 
is dependent  on  the  differentiation  of new  clones of immunocompetent  cells. 
The second mechanism, i.e.  that tolerogen directs an exodus of specific cells 
from tissues examined in the present study, is unlikely since it would predict the 
relocation of these specific cells to other lymphoid tissues, a prediction not sub- 
stantiated by the experimental findings. However, if antigen-directed exodus of 
cells occurs, its induction would be restricted to a tolerogenic form of the antigen 
since,  after the injection of immunogen,  a  similar disappearance of ABC  was 
never observed. 
The third possible explanation for the present data, i.e. that the receptors of 
specific cells are saturated with antigen, is a possiblity that gains support from 
the  recent  findings  that,  in  vitro,  the  state  of  tolerance  may  be  reversed 
during the earl}' phase of the induction process by trypsinization (15),  a  treat- 
ment  that  presumably removes bound  antigen  from  the  surface  of  the  cell. 
However,  the  reversal  of  tolerance  by this  apparent  enzymatic  stripping of 
receptors can be affected only as long as 36-48  h  after the initial  exposure of 
2 Chiller, J. M., and W. O. Weigle. Manuscript in press. Cell.  Immz~nol. J.  LOUIS,  J.  M.  CIIILLER,  AND  W.  O.  WEIGLE  467 
cells to antigen, after which time the tolerant state is refractive to enzyme treat- 
ment  3 (15).  It  appears,  therefore,  that  the  cell  membrane events  that  occur 
during  the induction  of tolerance may be divisible into  two phases:  an early 
phase reversible by trypsinization, and a later phase irreversible by trypsiniza- 
tion. From this standpoint, the initial disappearance of ABC in tolerant lymph- 
old tissues could be interpreted as a reflection of antigen saturation of receptor 
sites; but continued reduction of ABC for as long as 20 days after the injection 
of tolerogen may reflect yet another cellular manifestation. It may be that  at 
this time either clonal elimination or the fourth proposed mechanism, i.e. recep- 
tor shedding, is operational. 
The finding of a decrease in specific ABC in mice made unresponsive to HGG 
is in agreement with a similar reduction in ABC observed in the tolerant state in 
guinea pigs to 2,4-dinitrophenol and glutamic acid-lysine copolymers (6) and in 
mice to BSA (5), but contrasts with other reports demonstrating a normal level 
of ABC in states of tolerance in rats to flagellin (2)  and hemocyanin (3)  and in 
mice to the lipopolysaccharide of Escherichia coli (16). These apparent contra- 
dictions should be viewed as cellular manifestations of divergent mechanisms bv 
which tolerance to various antigens may be induced. 
In the case of thymus-dependent antigens, it has been shown that unrespon- 
siveness at  either  T  or B  cell  levels is sufficient  to  render  the  whole  animal 
tolerant (7). Tolerance to flagellin and to hemocyanin, both thymus-dependent 
antigens,  may be restricted to T  cell  tolerance under  the experimental condi- 
tions used,  respectively, by Ada et al.  (2)  and Cooper et al.  (3).  Inasmuch as 
ABC detected in the spleens to flagellin and hemocyanin are B  cells (17),  the 
level of ABC in a state of tolerance that did not involve unresponsiveness at the 
B  cell  level should not be expected to deviate from that observed in a normal 
state. Cells binding radioactive HGG are also B cells, a conclusion derived from 
the  observation  that  spleens  from  mice  thymectomized,  irradiated,  and  re- 
constituted with anti-0-treated BM cells displayed a normal level of ABC.  4 The 
observed disappearance of specific ABC in tolerance to HGG is in accord with 
the fact that, under the conditions presently used, the state of tolerance to this 
antigen is known to induce unresponsiveness in both specific T  celts and B cells 
(8). 
The presence of ABC in a tolerant state that involves a thymus-independent 
antigen, such as the lipopolysaccharide of E. coli,  requires yet another explana- 
tion. It is probable that mice other than germfree animals have been stimulated 
by this antigen, since it is present as part of the normal intestinal flora. Thus, 
the induction  of tolerance to this antigen may be a  model for what occurs in 
primed  B  cells,  and  the  cellular  and  subcellular  mechanisms  by which  this 
phenomenon occurs may be strikingly different from those that take place in 
3 Katz, D. H., T. Hanaoka, and B. Benacerraf. 1972. Immunological  tolerance in B lympho- 
cytes. I. Evidence for an intracellular mechanism of inactivation of hapten-specific  precursor 
of antibody-forming cells. Manuscript submitted for publication. 
4 Louis, J., J. M. Chiller, and W. O. Weigle. Manuscript in preparation. 468  FATE  OF  ANTIGEN-BINDING CELLS 
unprimed cells. Certainly, the ease with which reversibility of the tolerant state 
occurs in cell transfer experiments to an antigen-free environment with antigens 
such  as  E.  coli  polysaccharide  (16),  pneumococcal  polysaccharide  (18),  and 
sheep erythrocytes (19)  appears to be unique to antigens that induce a state of 
immunity before achieving tolerance. This is in contrast to the irreversible state 
of unresponsiveness to HGG, whose induction in normal mice does not include a 
phase of antibody formation (20). 
The numbers of specific ABC in the spleens of mice injected with immuno- 
genic HGG began  to increase as soon  as 24 h  after the  injection  of antigen, 
peaked at 3 days, and by 20 days rescinded to a level not significantly different 
from that present in  the spleens of normal aniinals. Although normal and im- 
mune cell populations are quantitatively similar at day 20, they are apparently 
qualitatively  different.  This  conclusion  is  based  on  the  observation  that  the 
[12~I]HGG binding by cells from immune mice was inhibited by much smaller 
amounts of unlabeled HGG than that needed to inhibit binding by cells from 
normal mice. These data confirm those obtained by others (21,  22)  and suggest 
that, compared with normal spleens, immune spleens have a restricted spectrum 
of specific cells,  with greater affinity receptors. 
SUMMARY 
Antigen-binding cells (ABC) to the antigen human gamma globulin (HGG) 
were  quantitated  in  lymphoid tissues of A/J  mice at various  times  after the 
injection of deaggregated HGG (tolerogen), aggregated HGG (immunogen), or 
saline. The reaction of lymphoid cells with highl} labeled HGG was  specific to 
that antigen since binding could be inhibited by excess unlabeled HGG, but not 
by unrelated  non-cross-reacting proteins.  Compared with  normal  mice,  there 
was a marked decrease in the numbers of ABC in the spleens of unresponsive 
animals evident as early as 12 h  after the injection of tolerogen. A marked in- 
crease in  ABC  was  observed in  the  spleens of immunogen-injected mice,  be- 
ginning at 24 h and reaching a peak at 3 days. In bone marrow, no difference in 
the number of ABC was found among the three experimental groups until day 
20, when a reduction in ABC was observed only in tolerogen-injected mice. No 
quantitative  difference in  the  thymuses in  the  experimental  groups  could  be 
determined because of the paucity of ABC displayed by normal thymus cells. 
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